Production (Stage)
KP Tissue Inc.
KPTSF
$6.56
$0.030.46%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- |
| Operating Income | -- | -- | -- | -- | -- |
| Income Before Tax | 45.11% | -185.76% | 16.34% | -41.87% | 116.72% |
| Income Tax Expenses | -- | -74.68% | -- | -- | -- |
| Earnings from Continuing Operations | 45.11% | -197.93% | 16.34% | -41.87% | 110.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.11% | -197.93% | 16.34% | -41.87% | 110.63% |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 44.66% | -197.72% | 16.12% | -42.03% | 110.61% |
| Normalized Basic EPS | 76.24% | -367.29% | 23.89% | -40.95% | 112.32% |
| EPS Diluted | 44.66% | -197.72% | 16.12% | -42.03% | 110.61% |
| Normalized Diluted EPS | 76.24% | -367.29% | 23.89% | -40.95% | 112.32% |
| Average Basic Shares Outstanding | 0.26% | 0.24% | 0.22% | 0.20% | 0.18% |
| Average Diluted Shares Outstanding | 0.26% | 0.24% | 0.22% | 0.20% | 0.18% |
| Dividend Per Share | -6.07% | -2.80% | -1.64% | -1.87% | 0.30% |
| Payout Ratio | -0.36% | -1.99% | -0.15% | 0.67% | 10.50% |